Close Menu

Share and Share Alike

The biotech industry is important for the creation of new drugs, job growth, and the health of the overall economy, but companies in this sector have continually found it challenging to raise the money they need to operate, says biopharmaceutical investment professional Mark Kessel in The Scientist. One solution, he says, would be for big pharma to create a biotech fund that utilizes pharma's cash to support biotech where needed.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Matt Hancock, the UK health secretary, is calling for the swift rollout of predictive genetic tests, the Guardian reports.

A WHO panel is calling for a global registry of human germline gene-editing projects, according to Stat News.

Vox writes that lab mishaps involving pathogens are quite common.

In Genome Biology this week: analysis of wild and cultivated peach genomes, Hi-C-based pipeline for assembling microbial genomes from metagenomic data, and more.